Britain's FTSE 100 index is seen opening 6 points higher at 6,268 on
Tuesday, according to financial bookmakers.
* ASTRAZENECA: An experimental vaccine being developed by AstraZeneca
and Oxford University against the new coronavirus produced an immune
response in early-stage clinical trials, data showed on Monday, preserving hopes
it could be in use by the end of the year.
* SYNAIRGEN: Synairgen shares rose almost sixfold on Monday after
the drugmaker said its medicine helped reduce the risk of severe cases in
hospitalised patients with COVID-19, but some experts have cautioned against too
much optimism in the market.
* BHP Group on Tuesday posted a 7% rise in fourth-quarter iron ore
output, but warned the resurgence of COVID-19 outbreaks threatened the
short-term demand outlook for its key commodities and widened its production
guidance range for next year.
* RBS: Royal Bank of Scotland has told staff that the "vast
majority" can continue to work from home until 2021, despite the British
government's decision last week to scrap guidance encouraging people to work
from home from next month.
* The UK blue-chip index closed down 0.5% on Monday, with energy
stocks tracking a decline in oil prices, while AstraZeneca marked its strongest
close ever on optimism over its COVID-19 vaccine.
* UK CORPORATE DIARY:
Gresham Technologies HY earnings release
RPS Group Plc Q2 trading statement
Intermediate Capital Group Plc Trading statement
Euromoney Institutional Investor Plc Q3 trading statement
* For more on the factors affecting European stocks, please click on:
TODAY'S UK PAPERS
> Financial Times
> Other business headlines
(Reporting by Samantha Machado in Bengaluru)
Our Standards: The Thomson Reuters Trust Principles.